AI Article Synopsis
- The study investigates how metabolic syndrome components relate to cognitive problems in schizophrenia patients.
- The research involved 133 patients and used the BACS test for cognitive assessment while following International Diabetes Federation criteria for metabolic syndrome.
- Findings indicate that hyperglycemia negatively impacts verbal fluency and attention, while abdominal obesity is linked to reduced executive functions, suggesting that treating these metabolic issues could improve cognitive abilities in these patients.
Article Abstract
Objective: To study the relationship between the individual components of the metabolic syndrome and cognitive dysfunction in patients with schizophrenia.
Material And Methods: A total of 133 patients with schizophrenia were examined. To assess cognitive functioning, the Brief Assessment of Cognition in Schizophrenia (BACS) was used. The components of the metabolic syndrome were determined in accordance with the criteria of the International Diabetes Federation.
Results: Hyperglycemia in patients with schizophrenia led to a decrease in cognitive functioning in two domains: verbal fluency (β=-10.67; =0.019) and attention stability (β=-9.519; =0.043). Abdominal obesity was associated with lower indicators of executive functions (β=-8.856; =0.026).
Conclusion: It is assumed that drug treatment of some components of the metabolic syndrome may affect cognitive functions in patients with schizophrenia.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17116/jnevro202412403182 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!